AVITA Medical, Inc. (RCEL)
12.98
-0.23
(-1.74%)
USD |
NASDAQ |
Oct 12, 12:03
AVITA Medical Net Income (TTM) : -43.08M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -43.08M |
| March 31, 2026 | -45.34M |
| December 31, 2025 | -48.59M |
| September 30, 2025 | -48.56M |
| June 30, 2025 | -51.57M |
| March 31, 2025 | -57.05M |
| December 31, 2024 | -61.84M |
| September 30, 2024 | -57.32M |
| June 30, 2024 | -49.83M |
| March 31, 2024 | -44.82M |
| Date | Value |
|---|---|
| December 31, 2023 | -35.38M |
| September 30, 2023 | -33.67M |
| June 30, 2023 | -30.54M |
| March 31, 2023 | -26.42M |
| December 31, 2022 | -26.66M |
| September 30, 2022 | -26.03M |
| June 30, 2022 | -26.44M |
| March 31, 2022 | -25.82M |
| June 30, 2021 | -26.58M |
| March 31, 2021 | -34.78M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Halozyme Therapeutics, Inc. | 413.60M |
| Iovance Biotherapeutics, Inc. | -289.52M |
| Agenus, Inc. | 91.94M |
| Amgen, Inc. | 8.743B |
| Editas Medicine, Inc. | -73.95M |